KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Sales (2016 - 2025)

Jazz Pharmaceuticals has reported Return on Sales over the past 16 years, most recently at 0.17% for Q4 2025.

  • Quarterly Return on Sales fell 1.0% to 0.17% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.08% through Dec 2025, down 22.0% year-over-year, with the annual reading at 0.08% for FY2025, 22.0% down from the prior year.
  • Return on Sales was 0.17% for Q4 2025 at Jazz Pharmaceuticals, down from 0.22% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.22% in Q3 2025 and troughed at 0.69% in Q2 2025.
  • The 5-year median for Return on Sales is 0.09% (2023), against an average of 0.01%.
  • Biggest five-year swings in Return on Sales: soared 52bps in 2022 and later tumbled -85bps in 2025.
  • Tracing JAZZ's Return on Sales over 5 years: stood at 0.04% in 2021, then crashed by -584bps to 0.25% in 2022, then soared by 138bps to 0.09% in 2023, then soared by 88bps to 0.18% in 2024, then dropped by -3bps to 0.17% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.17%, 0.22%, and 0.69% for Q4 2025, Q3 2025, and Q2 2025 respectively.